🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareCost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — looking for input Page 3

Cost-effectiveness analysis: GLP-1 agonists vs bariatric surgery (ICER 2026) — looking for input

SkepticalSean Sat, Sep 27, 2025 at 2:23 AM 14 replies 1,388 viewsPage 3 of 3
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Oct 2, 2025 at 9:11 PM#11
Dr.LipidDallas said:
Dr.ReproEndo said: ...surgery and anaesthesia should be combined with bariatric surgery...

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

44 19Dr.NateNeph, PharmD_Rodriguez, julia.endo and 41 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Oct 3, 2025 at 2:24 AM#12
RunnerRach said:
Agreed, and coverage criteria are plan-specific rather than insurer-specific.

This answered a question I did not know how to ask. I will report back once I have actually tried it.

43 18Dr.PathRoch, mona_PHX, andrew_nyc and 40 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Oct 3, 2025 at 7:37 AM#13
Dr.LipidDallas said:
Dr.ReproEndo said: ...surgery and anaesthesia should be combined with bariatric surgery...

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

Worth separating that from cost and coverage, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

42 17mike.trainer_LA, sarah_nash92, FitDadDave and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Oct 3, 2025 at 12:49 PM#14

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

41 16VendorMark, COA_Karl, MikeFit_NJ and 38 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 3, 2025 at 6:01 PM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

Last edited: Oct 3, 2025 at 10:01 PM
40 15PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 37 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register